Document Detail


Production of TNF alpha by LPS-stimulated murine, rat and human blood and its pharmacological modulation.
MedLine Citation:
PMID:  8317328     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Tumour necrosis factor alpha (TNF alpha) has been reported to play a key role in the pathogenesis of sepsis and chronic inflammatory diseases, including rheumatoid arthritis and atherosclerosis, suggesting that agents which inhibit TNF alpha production may have therapeutic utility for the treatment of such conditions. Production of TNF alpha by LPS (lipopolysaccharide)-stimulated murine, rat and human heparinized blood was investigated. LPS (1-100 micrograms/ml) caused a similar concentration- and time-dependent stimulation of TNF alpha production by rat and human blood, achieving levels of 750-5000 U/ml (L929 bioassay) at 6 h. In contrast, TNF alpha production by LPS-stimulated murine blood was poor and variable (0-150 U/ml). Dexamethasone and pentoxifylline caused a concentration-dependent inhibition of TNF alpha production by LPS-stimulated human and rat blood with IC50s of 0.26 +/- 0.05 and 73.0 +/- 26.4 microM for human and 5.7 +/- 1.8 nM and 20.6 +/- 8.0 microM for rat blood, respectively. Therefore, LPS-stimulated rat and human, but not murine, blood are suitable systems for the detection and evaluation of inhibitors of TNF alpha production.
Authors:
S J Foster; L M McCormick; B A Ntolosi; D Campbell
Related Documents :
16925588 - Microglial glutamate uptake is coupled to glutathione synthesis and glutamate release.
20195728 - Prostaglandin i(2) analogues enhance growth-related oncogene-alpha expression in human ...
9496438 - Thalidomide protects mice against lps-induced shock.
9110418 - Calcium entry blockers increase interleukin-10 production in endotoxemia.
19781388 - Different expression of dectin-1 and toll-like receptor 2 in the lungs of different imm...
12461178 - Stat1 deficiency unexpectedly and markedly exacerbates the pathophysiological actions o...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Agents and actions     Volume:  38 Spec No     ISSN:  0065-4299     ISO Abbreviation:  Agents Actions     Publication Date:  1993  
Date Detail:
Created Date:  1993-07-29     Completed Date:  1993-07-29     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0213341     Medline TA:  Agents Actions     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  C77-9     Citation Subset:  IM    
Affiliation:
ICI Pharmaceuticals, Macclesfield, Cheshire, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Blood Cells / metabolism*
Dexamethasone / pharmacology
Humans
Lipopolysaccharides / pharmacology*
Mice
Mice, Inbred BALB C
Pentoxifylline / pharmacology
Rats
Tumor Necrosis Factor-alpha / antagonists & inhibitors,  biosynthesis*
Chemical
Reg. No./Substance:
0/Lipopolysaccharides; 0/Tumor Necrosis Factor-alpha; 50-02-2/Dexamethasone; 6493-05-6/Pentoxifylline

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Expression of mRNA for interleukin 6 by cells infiltrating epiretinal membranes in proliferative vit...
Next Document:  Effects of leflunomide (HWA 486) on expression of lymphocyte activation markers.